Refutation Rumble


A team of NASA researchers published a paper in Science in December 2010 in which they described a microbe called GFAJ-1 that they said could substitute arsenic for phosphorus in a percentage of its DNA backbone. But University of British Columbia microbiologist Rosie Redfield begged to differ and did so publicly on her blog, RRResearch. After careful examination, Redfield and many of her colleagues in the microbiology community were alarmed by the methods used in the paper, and found evidence that contamination may have occurred.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.